← Back to Screener
Orthofix Medical Inc. Common Stock (DE) (OFIX)
Price$12.39
Favorite Metrics
Price vs S&P 500 (26W)-14.42%
Price vs S&P 500 (4W)2.69%
Market Capitalization$516.66M
All Metrics
P/CF (Annual)15.49x
Book Value / Share (Quarterly)$11.30
P/TBV (Annual)1.59x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)21.30%
Cash Flow / Share (Quarterly)$-0.03
Price vs S&P 500 (YTD)-17.75%
Gross Margin (TTM)68.83%
Net Profit Margin (TTM)-11.21%
EPS (TTM)$-2.34
10-Day Avg Trading Volume0.25M
EPS Excl Extra (TTM)$-2.34
Revenue Growth (5Y)15.13%
EPS (Annual)$-2.33
ROI (Annual)-14.74%
Gross Margin (Annual)68.83%
Net Profit Margin (5Y Avg)-11.96%
Cash / Share (Quarterly)$2.06
Revenue Growth QoQ (YoY)1.97%
ROA (Last FY)-10.84%
Revenue Growth TTM (YoY)2.85%
EBITD / Share (TTM)$-1.13
ROE (5Y Avg)-17.61%
Operating Margin (TTM)-9.90%
Cash Flow / Share (Annual)$-0.03
P/B Ratio1.15x
P/B Ratio (Quarterly)1.33x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.74x
Net Interest Coverage (TTM)-4.19x
ROA (TTM)-11.03%
EV / EBITDA (TTM)52.58x
EPS Incl Extra (Annual)$-2.33
Current Ratio (Annual)2.45x
Quick Ratio (Quarterly)1.30x
3-Month Avg Trading Volume0.25M
52-Week Price Return-4.53%
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$9.47
P/S Ratio (Annual)0.63x
Asset Turnover (Annual)0.97x
52-Week High$16.99
Operating Margin (5Y Avg)-8.76%
EPS Excl Extra (Annual)$-2.33
CapEx CAGR (5Y)7.34%
Tangible BV CAGR (5Y)4.94%
26-Week Price Return-10.44%
Quick Ratio (Annual)1.30x
13-Week Price Return-15.61%
Total Debt / Equity (Annual)0.39x
Current Ratio (Quarterly)2.45x
Enterprise Value$609.921
Revenue / Share Growth (5Y)-0.19%
Asset Turnover (TTM)0.98x
Book Value / Share Growth (5Y)-9.29%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.42x
Pretax Margin (Annual)-11.04%
Cash / Share (Annual)$2.06
3-Month Return Std Dev30.82%
Gross Margin (5Y Avg)70.14%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)-8.18%
ROE (Last FY)-20.49%
Net Interest Coverage (Annual)-4.19x
EPS Basic Excl Extra (Annual)$-2.33
P/FCF (TTM)21.66x
Receivables Turnover (TTM)6.08x
Total Debt / Equity (Quarterly)0.39x
EPS Incl Extra (TTM)$-2.34
Receivables Turnover (Annual)6.08x
ROI (TTM)-14.69%
P/S Ratio (TTM)0.63x
Pretax Margin (5Y Avg)-10.64%
Revenue / Share (Annual)$20.76
Tangible BV / Share (Annual)$9.47
Price vs S&P 500 (52W)-34.36%
Year-to-Date Return-15.11%
5-Day Price Return3.62%
EPS Normalized (Annual)$-2.33
ROA (5Y Avg)-10.73%
Net Profit Margin (Annual)-11.21%
Month-to-Date Return12.21%
Cash Flow / Share (TTM)$-2.76
EBITD / Share (Annual)$-1.13
Operating Margin (Annual)-9.90%
LT Debt / Equity (Annual)0.35x
P/CF (TTM)15.49x
ROI (5Y Avg)-14.15%
LT Debt / Equity (Quarterly)0.35x
EPS Basic Excl Extra (TTM)$-2.34
P/TBV (Quarterly)1.59x
P/B Ratio (Annual)1.33x
Inventory Turnover (TTM)1.42x
Pretax Margin (TTM)-11.04%
Book Value / Share (Annual)$11.30
Price vs S&P 500 (13W)-16.29%
Beta0.89x
P/FCF (Annual)10.33x
Revenue / Share (TTM)$20.55
ROE (TTM)-20.38%
52-Week Low$10.24
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.27
4.17
4.09
4.09
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
OFIXOrthofix Medical Inc. Common Stock (DE) | 0.63x | 15.13% | 68.83% | -9.90% | $12.39 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Orthofix Medical Inc. is a medical device company specializing in orthopedic and spine solutions. The Global Spine segment, which generates the majority of revenue, provides bone growth therapies, spinal implants, biologics, and enabling technologies for spinal procedures. The Global Limb Reconstruction segment offers solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies.